Health Blueprint

Back to Longevity News

News summary

Traded: Venture Capital 🦄 on Instagram: "Warhound has raised $200 million at a $1.2 billion valuation to develop genetically engineered dogs for military, law enforcement, and emergency response teams. Backed by Sequoia, 8VC, Corner Ventures, NeoGenesis, Lux Capital, In-Q-Tel, Animal Capital, John Shahidi, and others, the company plans to use gene editing and cloning to improve the health, longevity, and performance of working dogs. According to Warhound, more than 80% of U.S. military working dogs come from Europe, and fewer than half reportedly qualify for service. Anduril will provide protective equipment, sensors, and technology to support the dogs and their handlers. Warhound expects its first dogs to be born in early 2027, with deployment targeted within two years. The technology remains unproven, raising questions about animal welfare, genetic engineering, and the future of defense. Would you support genetically engineered military dogs? #TradedVC #DefenseTech #Biotech #VentureCapital #MilitaryTechnology"

Source: traderVC • Published: 23 Oct 2026, 17:41

Summarized by Masters of Longevity from traderVC.

A news item about a startup pursuing gene-edited working dogs for defense and public-safety use, with context on investors and timelines. Open to get a concise primer on the company, its backers, and the ethical, technical, and deployment questions the story raises.

Traded: Venture Capital 🦄 on Instagram: "Warhound has raised $200 million at a $1.2 billion valuation to develop genetically engineered dogs for military, law enforcement, and emergency response teams. Backed by Sequoia, 8VC, Corner Ventures, NeoGenesis, Lux Capital, In-Q-Tel, Animal Capital, John Shahidi, and others, the company plans to use gene editing and cloning to improve the health, longevity, and performance of working dogs. According to Warhound, more than 80% of U.S. military working dogs come from Europe, and fewer than half reportedly qualify for service. Anduril will provide protective equipment, sensors, and technology to support the dogs and their handlers. Warhound expects its first dogs to be born in early 2027, with deployment targeted within two years. The technology remains unproven, raising questions about animal welfare, genetic engineering, and the future of defense. Would you support genetically engineered military dogs? #TradedVC #DefenseTech #Biotech #VentureCapital #MilitaryTechnology"
Key Takeaways
  • Warhound raised $200 million at a $1.2 billion valuation to develop genetically engineered working dogs.
  • Warhound expects first dogs born in early 2027 and targets deployment within two years.
Read the full article at traderVC ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.